Parallel Advisors, LLC Pliant Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$4.11 - $8.75 $2,704 - $5,757	-658 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$7.01 - $14.1 $525 - $1,057	-75 Reduced 10.23%	658 $5,000
Q4 2021 Jan 20, 2022	SELL	$12.27 - $18.26 $2,085 - $3,104	-170 Reduced 18.83%	733 $10,000
Q3 2021 Nov 02, 2021	BUY	$16.48 - $28.98 $4,037 - $7,100	245 Added 37.23%	903 $15,000
Q2 2021 Aug 06, 2021	BUY	$28.05 - $37.69 $18,456 - $24,800	658 New	658 $19,000
Q4 2020 Feb 02, 2021	SELL	$19.89 - $32.99 $13,087 - $21,707	-658 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$21.3 - $35.26 $14,015 - $23,201	658 New	658 $21,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $585M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.